6-Amino-5-bromonicotinic acid

Catalog No.: 
ACVISY950
CAS No.: 
180340-69-6
Molecular Formula: 
C6H5BrN2O2
Molecular Weight: 
217.02
6-Amino-5-bromonicotinic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
25g98%$122.00In stockIn stock
100g98%$350.00In stockIn stock
500g98%$1698.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name6-Amino-5-bromonicotinic acid
IUPAC Name6-amino-5-bromonicotinic acid
MDL No.MFCD11109515
Molecular FormulaC6H5BrN2O2
Molecular Weight217.02
SMILESO=C(O)C1=CN=C(N)C(Br)=C1
InChI KeyUOUDHTBHPQJUPS-UHFFFAOYSA-N
Synonym6-AMINO-5-BROMONICOTINIC ACID | 180340-69-6 | 6-amino-5-bromopyridine-3-carboxylic acid | 6-Amino-5-bromo-nicotinic acid | 3-Pyridinecarboxylic acid, 6-amino-5-bromo- | MFCD11109515 | 6-Amino-5-bromonicotinicacid | 2-Amino-3-bromo-5-pyridinecarboxylic acid | 6-amino-5-br
CAS No.180340-69-6
PubChem CID22742028

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P305+P351+P338

Synthetic Route by SureRoute

1. ACVISY950 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACKZMC187 route compound structure diagram
    ACKZMC187850429-51-5In Stock
  2. Then
  3. ACVISY950 route product structure diagram
    ACVISY950180340-69-6In Stock
Inquiry

2. ACVISY950 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVISY950 route product structure diagram
    ACVISY950180340-69-6In Stock
Inquiry

3. ACVISY950 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVISY950 route product structure diagram
    ACVISY950180340-69-6In Stock
Inquiry

Comments (0)